Step 1 topics → Biochemistry → Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu)

Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu)

USMLE Step 1 trap: Misclassifies HHT as X-linked rather than autosomal dominant with ENG/ALK1 mutations. HHT (Osler-Weber-Rendu) is autosomal dominant with mutations in ENG or ALK1, affecting TGF-β signaling in vascular endothelium.

Hereditary Hemorrhagic Telangiectasia (HHT, or Osler-Weber-Rendu syndrome) is an autosomal dominant vascular dysplasia caused by mutations in ENG (endoglin) or ALK1, both components of the TGF-β signaling pathway in vascular endothelium. The result is abnormal vessel formation — thin-walled, dilated connections between arteries and veins (telangiectasias and AVMs) that lack the normal capillary buffer. On USMLE Step 1, this disease shows up in clinical vignettes centered on recurrent nosebleeds or a family history of bleeding, and the question pivots to either the genetic mechanism, the classic triad, or a complication like stroke in a young person.

The exam tests HHT from three angles: recognizing the classic presentation triad, identifying the inheritance pattern and gene products, and reasoning through the downstream complications of visceral AVMs. The trickiest questions give you a young patient with a cryptogenic stroke or brain abscess and bury the HHT history. You're expected to connect pulmonary AVM → loss of the capillary filter → paradoxical embolism or septic embolism.

Two major traps appear here. First, students misclassify HHT as X-linked because vascular malformations pattern-match poorly to autosomal dominant diseases in their mental model — but HHT is cleanly AD, affecting males and females equally. Second, students conflate the surface telangiectasias (which are cosmetic and diagnostic) with the visceral AVMs (which kill). The lips and fingertips findings get you the diagnosis; the pulmonary, hepatic, and cerebral AVMs create the life-threatening complications that USMLE Step 1 loves to test.

From real student decks
49%have cards covering this topic
30%have mature cards

Common misconceptions

Common mistake
Wrong: HHT is X-linked because it involves vascular malformations that seem to affect males more visibly.
Right: HHT (Osler-Weber-Rendu) is autosomal dominant with mutations in ENG or ALK1, affecting TGF-β signaling in vascular endothelium.
HHT is autosomal dominant, not X-linked — it affects males and females equally, and a single mutated copy of ENG or ALK1 is sufficient to cause disease. The X-linked misconception probably comes from pattern-matching 'vascular malformations' to hemophilia or other X-linked bleeding disorders, but the mechanism here is completely different: it's a structural defect in vessel formation driven by TGF-β signaling, not a coagulation factor deficiency. When you see HHT on Step 1, anchor to AD + ENG/ALK1 + TGF-β.
Common mistake
Gap: Missing that pulmonary AVMs in HHT enable paradoxical embolism and brain abscess by bypassing the pulmonary capillary bed
Pulmonary AVMs in HHT bypass the pulmonary capillary filter, allowing venous thrombi or bacteria to reach the systemic circulation, causing paradoxical embolism or brain abscess.
Normally, the pulmonary capillary bed acts as a mechanical filter — clots and bacteria entering the venous system get trapped in the lungs before they can reach the brain or other organs. Pulmonary AVMs in HHT short-circuit this filter by creating direct artery-to-vein connections that skip the capillaries entirely. This means a venous thrombus or a bacteremia (even from something minor like a dental procedure) can travel straight to the systemic circulation, causing stroke or brain abscess in an otherwise young, healthy-seeming patient.
Common mistake
Gap: Missing the classic HHT triad and the distinction between surface telangiectasias and life-threatening visceral AVMs
The classic HHT triad is recurrent epistaxis, mucocutaneous telangiectasias, and a family history of the same — visceral AVMs (pulmonary, hepatic, cerebral) are the dangerous complications.
The classic HHT triad — recurrent epistaxis, mucocutaneous telangiectasias, and family history — is what gets you to the diagnosis, but it's not what kills the patient. The surface lesions on lips and fingertips are dilated capillaries that bleed easily but aren't dangerous on their own. The visceral AVMs in the lungs, liver, and brain are the high-stakes findings: pulmonary AVMs cause paradoxical embolism and hypoxia, hepatic AVMs cause high-output cardiac failure, and cerebral AVMs cause hemorrhagic stroke. On a vignette, the triad is your diagnostic key; the AVMs are your complication anchor.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Recognize that HHT is autosomal dominant, caused by loss-of-function mutations in ENG or ALK1, both of which disrupt TGF-β signaling in vascular endothelial cells.
  2. Identify the classic HHT triad: recurrent epistaxis, mucocutaneous telangiectasias (lips, tongue, fingertips), and a positive family history — and know this triad is diagnostic.
  3. Understand that visceral AVMs (pulmonary, hepatic, cerebral) are the dangerous complications of HHT, distinct from the surface telangiectasias that help you make the diagnosis.
  4. Reason through why pulmonary AVMs cause paradoxical embolism and brain abscess: they bypass the pulmonary capillary bed, which normally filters venous thrombi and bacteria, allowing them to enter the systemic arterial circulation.
  5. Connect high-output heart failure to hepatic AVMs in HHT, which create a large arteriovenous shunt that forces the heart to compensate with increased cardiac output.

Can you avoid these mistakes?

A 34-year-old woman presents with her third episode of epistaxis this year. Her mother and brother have similar histories. Physical exam shows small red lesions on her lips and tongue. What is the inheritance pattern, and which two genes are most commonly mutated in this condition?
A 28-year-old man with known HHT develops sudden left-sided weakness. MRI shows an acute ischemic stroke. A lower extremity Doppler reveals a DVT. What is the mechanism linking his HHT to his stroke, and which specific HHT complication made this possible?
A patient with HHT develops progressive dyspnea and signs of high-output heart failure. Imaging reveals large vascular malformations in the liver. Explain the hemodynamic mechanism by which hepatic AVMs cause high-output failure.
A 30-year-old woman with HHT undergoes a routine dental extraction. Two weeks later she presents with fever, headache, and a ring-enhancing lesion on MRI. What is the diagnosis, and what is the step-by-step pathway from dental procedure to brain lesion in the context of her underlying condition?

Related topics

Inheritance Patterns Nucleotide and Nucleic Acid Structure DNA Replication DNA Repair Pathways Mutations and Their Consequences

See how your Anki deck covers this topic.

Upload your deck for a free audit →